Status:
RECRUITING
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
25-80 years
Brief Summary
This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk i...
Detailed Description
PRIMARY OBJECTIVES: I. To establish a longitudinal cohort (n=10,000) of women who undergo routine annual mammography screening with follow-up for at least five years for each study participant or unt...
Eligibility Criteria
Inclusion
- Willingness to participate in the study and ability to provide informed consent
- Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
- Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.
Exclusion
- Current or recent (within the prior 6 months) history of breast feeding
- Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
- Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.
Key Trial Info
Start Date :
September 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03408353
Start Date
September 15 2017
End Date
April 30 2027
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030